BIOTECH Logo

BIOTECH

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Biat Group is a biotechnology corporate group that operates through its holding company, Bionatur, and a global commercial network. The group is composed of several subsidiaries with distinct specializations. Biobide is a leading provider of preclinical research, offering toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions leverages a proprietary set of inteins for high-value applications in gene therapy, immunotherapy, in-vitro diagnostics (IVD), smart vaccines, and protein purification. The Bionatur division holds unique biotech assets for human and animal health. The group seeks collaborations in licensing, preclinical research, and vaccine improvement.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for BIOTECH. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-03-19 14:18
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-18 10:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-17 14:38
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-14 10:53
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-13 15:33
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-12 14:50
Net Asset Value
Net Asset Value(s)
English 4.1 KB
2025-03-11 15:54
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-10 14:35
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 14:28
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-07 09:08
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 15:30
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-06 08:00
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-05 14:34
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-04 14:40
Net Asset Value
Net Asset Value(s)
English 4.0 KB
2025-03-03 15:43
Net Asset Value
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a blood test for early lung cancer detection using a proprietary CIZ1B biomarker.
United Kingdom CIZ
Combigene AB Logo Sweden COMBI
Compugen Ltd. Logo
AI-driven discovery of novel antibody therapies for cancer immunotherapy.
Israel CGEN
Virgin Islands (British) N/A
Cte Group Spolka Akcyjna Logo
Provides B2B services, corporate events, and advanced composite materials R&D.
Poland LPS
Curasight A/S Logo
Developing a theranostics platform for precise diagnosis and targeted radiation therapy for cancer.
Denmark CURAS
Cyclezyme AB Logo
Develops enzymes to recycle PET plastic waste into new high-quality materials.
Sweden CYCLE
Cyxone AB Logo Sweden CYXO
DARWIN AG Logo
AI-powered biotech creating personalized health solutions from biological data for B2C & B2B.
Germany 7V0
DBV Technologies Logo
Developing a non-invasive skin patch for epicutaneous immunotherapy to treat food allergies.
France DBV